| Select Employers | Business Sector | Employees | | CareFirst BlueCross BlueShield | Health insurance | 2,498 | | T. Rowe Price Associates | Financial services | 1,796 | | Solo Cup | Paper/plastic products mfg. | 1,600 | | Toyota Financial Services | Vehicle financing | 420 | | Global Payments | Financial services | 405 | | Aon | Business services | 400 | | Legg Mason | Financial services | 400 | | ADP | Business services | 385 | | Inovant | Credit card services | 300 | | Shire Pharmaceuticals | Pharmaceutical mfg. | 225 | | Baltimore Spice Company | Food flavorings mfg. | 170 | | Axalto | Credit card mfg. | 165 | | Baltimore Life Companies | Insurance/financial | 147 | | Smith Kline/Beecham | Pharmaceutical R&D | 125 | | Quest International | Food flavoring mfg. | 105 |
Owings Mills is the area's fastest-growing population center with over 70,000 people and the highest concentration of young, professionals in the County. Owings Mills benefits from more than $1.4 billion in transportation investment, including I-795 connecting to the Baltimore Beltway and Carroll County, and Metro subway, directly linking to downtown Baltimore and the Johns Hopkins medical campus. More than six million square feet of business development has been built since being named a growth area in 1983. A variety of homes are clustered around a core of commercial, office and industrial development, providing a balanced community to live and work. Financial Services, Manufacturing, Bio Class-A corporate campuses and flex parks flank a regional mall, restaurant park, and mixed-use Metro Center at Owings Mills adjacent to the Metro station. Corporate or division headquarters include Solo Cup, Baltimore Life Companies, ADP, and CareFirst BlueCross BlueShield. Major financial services operations centers for T. Rowe Price, Legg Mason, Baltimore Life Companies and Toyota Financial Services complement manufacturers such as Solo Cup, Baltimore Spice Company, Axalto, Quest International. A growing bioscience cluster includes U.K.-based Shire’s only U.S. pharmaceutical manufacturing facility, Smith Kline Beecham, and BioFX. |